Histone acetylation/deacetylation in Candida albicans and their potential as antifungal targets

Area of Science:

• Medical Mycology
• Molecular Biology
• Epigenetics

Background:

• Invasive fungal infections are increasing, with Candida albicans being a primary cause.
• Limited antifungal options and rising drug resistance necessitate new therapeutic strategies.
• Histone acetyltransferases (HATs) and histone deacetylases (HDACs) play crucial roles in C. albicans biology.

Purpose of the Study:

• To review the functions of HATs and HDACs in C. albicans.
• To identify potential antifungal targets within these epigenetic regulators.
• To explore compounds affecting histone acetylation and deacetylation for antifungal development.

Main Methods:

• Literature review of studies on HATs and HDACs in C. albicans.
• Analysis of the roles of histone acetylation in fungal growth, virulence, and drug resistance.
• Identification of potential therapeutic targets and compounds based on epigenetic mechanisms.

Main Results:

• HATs and HDACs are essential for C. albicans growth, virulence, and stress responses.
• Modulation of histone acetylation/deacetylation impacts fungal drug resistance.
• Several HAT/HDAC-related pathways present viable targets for antifungal intervention.

Conclusions:

• Targeting HATs and HDACs represents a promising avenue for novel antifungal drug discovery.
• Understanding epigenetic regulation in C. albicans can lead to new treatment strategies.
• Further research into HAT/HDAC inhibitors could combat rising antifungal resistance.